Former Army TBI Research Leader Col. Dallas Hack Joins Astrocyte Pharmaceuticals’ Scientific Advisory Board
Cambridge, MA, December 19, 2016 – Astrocyte Pharmaceuticals Inc., a privately held pharmaceutical company, announced today that Colonel (retired) Dallas C. Hack, MD, MPH has joined the company’s Scientific Advisory Board. Astrocyte Pharmaceuticals is developing novel small molecule therapeutics for acute administration to patients who have suffered a stroke, traumatic brain injury (TBI) or concussion. […]